Pediatrix Medical Group Inc. Common Stock (MD)
Stock · NYSE · Health Care
$27.39as of 10/16/2026
Price chart
Active signals
MD Signal Track Record
How signals performed across all stocks →What MD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | +0.5% | 51% | September 18, 2026 |
| Bollinger Band Breakdown | 20 | -0.5% | 50% | September 17, 2026 |
| Bollinger Band Breakout | 21 | -1.3% | 48% | July 1, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -12.7% | 20% | June 25, 2025 |
| Any 20-session window (baseline) | +0.1% | 50% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric…
- Sector
- Health Care
- Industry
- Hospital/Nursing Management
- Employees
- 4,280
- Website
- www.pediatrix.com/
Fundamentals
- 1-day range
- $26.7$27.08
- Market cap
- $2.15B
- P/E (trailing)
- 12.55
- P/E (forward)
- 10.99
- EPS (trailing)
- $2.08
- Dividend yield
- —
- Beta
- 0.64
- Avg. volume
- 771.1K
How Pediatrix Medical Group Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
Pediatrix Medical Group Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MDPediatrix Medical Group Inc. Common Stock$27.38▼ 1.37%Market cap $2.15BP/E 12.55$15.82$27.94
- SGRYSurgery Partners Inc. Common Stock$14.61▼ 1.08%Market cap $1.95BP/E —$11.41$23.44
- SNDASonida Senior Living Inc. Common Stock$35.29▼ 1.62%Market cap $1.91BP/E —$24.95$44.39
- ARDTArdent Health Inc. Common Stock$11.95▼ 2.05%Market cap $1.66BP/E 21.49$7.71$15.48
- HCSGHealthcare Services Group Inc. Common Stock$21.13▼ 1.40%Market cap $1.51BP/E 11.90$15.5$25.75
- NHCNational HealthCare Corporation Common Stock$242.82▼ 1.10%Market cap $3.43BP/E 26.97$117.22$239.29
- BKDBrookdale Senior Living Inc. Common Stock$10.09▲ 0.00%Market cap $3.43BP/E —$8.02$17.09
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MD Pediatrix Medical Group Inc. Common Stock | $2.15B | 12.55 | $27.38 | ▼ 1.37% | $15.82$27.94 |
| SGRY Surgery Partners Inc. Common Stock | $1.95B | — | $14.61 | ▼ 1.08% | $11.41$23.44 |
| SNDA Sonida Senior Living Inc. Common Stock | $1.91B | — | $35.29 | ▼ 1.62% | $24.95$44.39 |
| ARDT Ardent Health Inc. Common Stock | $1.66B | 21.49 | $11.95 | ▼ 2.05% | $7.71$15.48 |
| HCSG Healthcare Services Group Inc. Common Stock | $1.51B | 11.90 | $21.13 | ▼ 1.40% | $15.5$25.75 |
| NHC National HealthCare Corporation Common Stock | $3.43B | 26.97 | $242.82 | ▼ 1.10% | $117.22$239.29 |
| BKD Brookdale Senior Living Inc. Common Stock | $3.43B | — | $10.09 | ▲ 0.00% | $8.02$17.09 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 3 Healthcare Stocks That Concern UsYahoo · 9/30/2026
- Can Pediatrix Sustain Growth Despite Lower Patient Volumes?Yahoo · 9/22/2026
- Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its PullbackYahoo · 9/21/2026
- 1 Safe-and-Steady Stock to Research Further and 2 We Turn DownYahoo · 9/18/2026
- Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep FallingYahoo · 9/16/2026
- 3 Stocks Under $50 with Questionable FundamentalsYahoo · 9/14/2026
Insider Activity
Insider Actions →- Laura A. Linynsky · September 10, 2026 · Disposition6.0K @ $26.82
- Sylvia Jean Young · August 14, 2026 · Disposition18.5K @ $26.62
- Laura A. Linynsky · August 12, 2026 · Grant472 @ $26.5
- Guy P. Sansone · August 12, 2026 · Grant472 @ $26.5
- Kurt Douglas Newman · August 12, 2026 · Grant472 @ $26.5
- Sylvia Jean Young · August 12, 2026 · Grant472 @ $26.5
- Thomas McEachin · August 12, 2026 · Grant472 @ $26.5
- Shirley A. Weis · August 12, 2026 · Grant472 @ $26.5
- Michael A. Rucker · August 12, 2026 · Grant472 @ $26.5
- John M. Starcher Jr. · August 12, 2026 · Grant472 @ $26.5
- David Haddock · June 22, 2026 · Grant51.0K
- David Haddock · June 22, 2026 · Grant20.0K
- Mary Ann E. Moore · June 9, 2026 · Gift18.4K
- Mark S. Ordan · June 2, 2026 · Grant97.2K
- Mark S. Ordan · June 2, 2026 · Disposition97.2K
Institutional Ownership
March 31, 2026
- Total shares held
- 75.37M
- Total value held
- $1.57B
- Institutional holders
- 287
- Unknown13.57M
- Unknown3.93M
- Unknown3.86M
- Unknown3.84M
- Unknown3.66M
- Unknown3.38M
- Unknown2.27M
- Unknown2.19M
- Unknown2.05M
- Unknown1.71M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
MD mentioned in list of stocks with questionable fundamentals
Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.
MD mentioned in list of stocks with questionable fundamentals. Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.